Author Archives: furocyst

TEAM FENFURO had participated in UPDACON-annual congress of Uttar Pradesh Diabetes Association which was held on 17 & 18 November 2012 at Scientific Convention Center, CSMMU ,Lucknow, the state capital of Uttar Pradesh which happens to be highest populated state of India. The conference was attended by more than 600 physicians and endocrinologists who put their idea to fight with Diabetes and create awareness among people for the prevention of diabetes and they have also promoted life style modifications as well as motivated people for early detection and treatment and to avoid late life threatening complications of Diabetes. It was the endeavor to update physicians and general practitioners about newer modalities of diagnosis and treatment.

TEAM FENFURO participated in 6th World Ayurveda Congress & Arogya held at Pragati Maidan, New Delhi from 06th to 09thNovember 2014. Free catalogues/informative material were distributed among visitors for awareness of Diabetes and its complications, Obesity, PCOS(ploycystic ovarian syndrome) & General Health.

Participated in 11th annual congress of Uttar Pradesh Diabetes Associations

TEAM FENFURO had participated in UPDACON-annual congress of Uttar Pradesh Diabetes Association which was held on 17 & 18 November 2012 at Scientific Convention Center, CSMMU ,Lucknow, the state capital of Uttar Pradesh which happens to be highest populated state of India. The conference was attended by more than 600 physicians and endocrinologists who put…

Diabetes Drug May Affect Thyroid in Some Patients

Medicine tied to lower thyroid-stimulating hormone levels in those with underactive thyroid WebMD News from HealthDay , By Mary Elizabeth Dallas, HealthDay Reporter MONDAY, Sept. 22, 2014 (HealthDay News) –Metformin, a drug commonly used to treat diabetes, may raise the risk of low levels of thyroid-stimulating hormone (TSH) among patients with an under active thyroid,…

Taking Insulin for T2 Diabetes Could Expose Patients to Greater Risk of Health Complications

Patients with type 2 diabetes treated with insulin could be exposed to a greater risk of health complications including heart attack, stroke, cancer and eye complications a new study has found. Examining the UK Clinical Practice Research Datalink (CPRD) – data that characterizes about 10 percent of the UK population – a team of researchers…